Development of albumin monitoring system with hepatic hypoxia-on-a-chip.

Hypoxia plays an essential role in the pathogenesis of various liver diseases, and albumin is one of the important biomarkers secreted by the liver. In this study, we developed an albumin monitoring system composed of hepatic hypoxia-on-a-chip and an albumin sensor to study liver function change due to hypoxia. In hepatic hypoxia-on-a-chip, we vertically stack an oxygen-scavenging channel on a liver on a chip with a thin gas-permeable membrane in the middle. This unique design of the hepatic hypoxia-on-a-chip can help to induce hypoxia quickly, attaining <5% within 10 min. An electrochemical albumin sensor was fabricated based on the covalent immobilization of antibodies on the Au electrode to monitor albumin secreting function on the hepatic hypoxia-on-a-chip. Standard albumin samples spiked in PBS, and culture media were measured by the electrochemical impedance spectroscopy using the fabricated immunosensor. The LOD was calculated to be 10 ag/mL in both cases. Using the electrochemical albumin sensor, we measured albumin secretion in normoxia and hypoxia in the chips. The albumin concentration decreased to 27% after 24 h in hypoxia compared to normoxia. This response was consistent with physiological studies. With technical refinements, the present albumin monitoring system can be a powerful tool in studying hepatic hypoxia with real-time liver function monitoring. [Display omitted] • Hepatic hypoxia-on-a-chip was developed based on the vertically stacked oxygen-scavenging channel. • Hepatic hypoxia-on-a-chip induces stable hypoxia within 10 min. • Electrochemical biosensor was developed to monitor albumin secreting function on the hepatic hypoxia-on-a-chip. • Albumin concentration was monitored to be decreased to 27% after 24 h in hypoxia compared to normoxia. [ABSTRACT FROM AUTHOR]